 Economic Times [1] |
Lyxumia, Sanofi's Type 2 Diabetes Treatment, Approved in EU [2]
A Sweet Life (blog) Lyxumia is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of patients with type 2 diabetes mellitus. GLP-1 is a naturally-occurring peptide hormone that is released within minutes after eating a meal. It is known to suppress … Sanofi's diabetes drug Lyxumia approved in Europe [1]Economic Times Sanofi Gets Marketing Authorization For Lyxumia in Europe [3]Fox Business all 4 news articles » [4] |
More details can be found at www.diabeteshowto.com [5]